Related Experiment Videos
Epithelioid sarcoma of the hand
Mark J Herr1, William S Harmsen, Peter C Amadio
1Department of Orthopedic Surgery, Mayo Clinic, 200 SW First Street, Rochester, MN 55905, USA.
Clinical Orthopaedics and Related Research
|February 3, 2005
Summary
Aggressive surgical management of primary epithelioid sarcoma of the hand leads to high survival rates. Achieving negative margins resulted in 71% of patients being disease-free, with 85% 5- and 10-year survivorship.
Area of Science:
- Orthopedics
- Surgical Oncology
- Hand Surgery
Background:
- Epithelioid sarcoma of the hand is a rare and aggressive soft tissue tumor.
- Many patients present with a history of prior excisions and misdiagnoses, complicating initial treatment.
- Effective management requires a multidisciplinary approach focusing on complete tumor resection.
Purpose of the Study:
- To evaluate the effectiveness of preoperative imaging in diagnosing epithelioid sarcoma of the hand.
- To determine the role of adjuvant therapy in improving outcomes.
- To analyze survival rates and functional outcomes following various surgical resection strategies.
Main Methods:
- Retrospective review of 28 patients with primary epithelioid sarcoma of the hand.
- Analysis of surgical management including wide excision, partial hand amputation, and forearm amputation.
- Assessment of preoperative imaging, adjuvant therapies, and long-term follow-up data.
Main Results:
- Aggressive surgical management with negative margins achieved disease-free status in 71% of patients.
- Five- and 10-year survivorship rates were 85%.
- Treatment failures included local recurrence, regional metastases, and distant metastases, with 5 disease-related deaths.
Conclusions:
- Complete surgical resection with negative margins is critical for favorable outcomes in epithelioid sarcoma of the hand.
- Adjuvant therapies and preoperative imaging play roles in optimizing treatment and should be further investigated.
- Despite challenges, aggressive surgical intervention offers a significant chance for long-term survival and disease control.